Amrubicin (Japan only) Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 3: 1

Top Sponsors

Gilead Sciences1

Indications

Extensive Stage Small Cell Lung Cancer (ES-SCLC)1
Lung Cancer1
Cancer1

Hot Springs, Arkansas1 trial

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

Genesis Cancer and Blood Institute

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.